Researchers at the University of São Paulo in the Department of Neuroscience and Behavior, in Brazil, tested the effects of cannabidiol on Parkinson’s patients suffering from RBD sleep disorder. Patients received either 75mg or 300mg of CBD per day for a 6-week period. During the case study, all patients showed a “prompt and substantial reduction in the frequency of RBD-related events without side effects.” Their study confirmed that CBD was successfully able to control RBD symptoms in Parkinson’s patients and was published in the Journal of Clinical Pharmacy and Therapeutics.
As the research surrounding this remarkable compound continues to progress, we look forward to reviewing the research. To read the full text of the study cited in this article, please see here.